Reproductive dysfunction is unusually common among women and men who have epilepsy.
Reproductive dysfunction in women with epilepsy Hospital 2,7,8 and community-based 9 studies have shown that menstrual disorders are more common among women with epilepsy than in the general Seizure (2008) Summary Reproductive disorders are unusually common among women and men with epilepsy. They are generally associated with and may be the consequence of reproductive endocrine disorders. Both epilepsy itself and antiepileptic drug use have been implicated in their pathophysiology. This review focuses on how temporolimbic dysfunction in epilepsy may disrupt normal neuroendocrine regulation and promote the development of reproductive endocrine disorders. The particular nature of the dysregulation may relate to the laterality and focality of the epilepsy and some hormonal changes may develop in close temporal relation to the occurrence of epileptiform discharges. In women, reproductive endocrine disorders include polycystic ovary syndrome, hypothalamic amenorrhea, functional hyperprolactinemia, and premature menopause. In men, hypogonadism may be hypogonadotropic, hypergonadotropic or related to hyperprolactinemia. The significance of these reproductive endocrine disorders is that they may contribute not only to sexual dysfunction and infertility but may also have an adverse impact on seizure control. # 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
population. Menstrual disorders can be categorized as amenorrhea (no menses for 6 months), oligomenorrhea (cycle intervals >32 days), polymenorrhea (cycle intervals <26 days), abnormal variation in cycle intervals (>4 days), and menometrorrhagia (heavy menses and bleeding between menses. 10 Cycle intervals between 26 and 32 days, rather than the currently popular broader range of 21-35 days, should be considered normal in women with epilepsy because ovulatory rates drop substantially and statistically significantly, i.e. from >75% to <50%, outside of the 26-32 day range. 10 Ovulation is considered to be an important criterion in this population because anovulatory cycles are associated with greater seizure frequency. 11, 12 Menstrual disorders, using the above definition, are currently estimated to occur in one-third of women with epilepsy as compared 12-14% of women in the general population. 6, 10 More than one-third of cycles in women with localization-related epilepsy are anovulatory, as compared to 8-10% in controls. 10, [13] [14] [15] There is conflicting evidence as to whether anovulatory cycles are more common with localization-related epilepsy or primary generalized epilepsy. [13] [14] [15] Women with idiopathic epilepsy are only 37% as likely as unaffected female siblings to become pregnant. 16 This finding is not attributable to marital rate or to seizure type, age at onset, or family history of epilepsy. 16 In comparison to the general female population, fertility is reduced to 69-85% of the expected number of offspring among married women with epilepsy, primarily TLE. 17, 18 Reproductive endocrine disorders in women with epilepsy
The most common reproductive endocrine disorder in women with epilepsy as well as women in the general population is polycystic ovary syndrome (PCOS). 2, 19, 20 PCOS occurs in 10-20% of women with epilepsy compared with 5-6% of women in the general population. 6, 7, 18, 20 This increased rate of occurrence may be of considerable medical significance because PCOS is associated with a higher prevalence of migraine, emotional disorders, diabetes, cardiovascular disease, and female cancers in the general population. 20 PCOS is probably not a single nosologic entity, but rather the common end point for a number of pathophysiologic mechanisms, some of which may be attributable to epilepsy itself 2, 7, 19, 20 or to the use of AEDs, most notably valproate. 5, 14, 15, 21 PCOS represents the failure of the ovarian follicle to complete normal maturation during the menstrual cycle or a series of cycles, a failure that is perhaps related to the presence of inadequate levels of pituitary follicle-stimulating hormone (FSH), while levels of luteinizing hormone (LH) are normal or elevated. 7, 20 These conditions can produce two results. There is a failure of ovulation and the partially developed follicle is retained in the ovary in the form of a tiny cyst. 7, 20 This partially developed follicle is secretory but deficient in aromatase, the enzyme that converts testosterone to estrogen, and, therefore has testosterone as its principal secretory product. Testosterone may increase the positive feedback of estrogen on pituitary LH secretion, 21 resulting in increased ovarian steroid secretion, which, under these circumstances, may be predominantly testosterone and can result in hyperandrogenism. The testosterone is aromatized in peripheral adipose tissue, generally producing high-normal levels of estrogens which is a major source of the estrogen feedback on the pituitary. The persistent occurrence of such cycles results in hyperandrogenic chronic anovulation, which is currently the simplest and perhaps the most utilitarian definition of PCOS. 20, 22 Hypothalamic amenorrhea (HA -amenorrhea associated with low gonadotropin and estrogen levels and diminished LH response to gonadotropin releasing hormone (GnRH) challenge), functional hyperprolactinemia (elevated prolactin levels without identifiable pituitary lesion) and premature menopause (cessation of ovarian function featuring amenorrhea and elevated gonadotropin levels) have also been found to be overrepresented in women with epilepsy. 2, 7, 18, 23, 24 In an investigation of 50 consecutive women with clinical and electroencephalographic features of TLE, 28 (56%) had amenorrhea, oligomenorrhea, or abnormally long or short menstrual cycle intervals. 2 Nineteen of the 28 women with epilepsy and menstrual disorders (68%, 38% overall) had readily identifiable reproductive endocrine disorders: PCOS in 10, hypothalamic amenorrhea in 6 (12%), premature menopause, in this study before 30 years of age, in 2 (4%), and functional hyperprolactinemia in 1 (2%). The numbers of women with clinical and endocrine features of PCOS (20%) and of HH (12%) were significantly greater than the estimated frequencies (5% for PCOS and 1.5% for HH) in the general female population.
The data showed no significant relationship overall between the occurrence of menstrual disorders and the use of AEDs (53% among users versus 60% among nonusers) and raised the possibility that epilepsy itself may be a factor. 2 PCOS was more common among the untreated (30%) than the treated (13%) women with epilepsy. Treatment AEDs were of the enzyme-inducing variety. The lesser occurrence of PCOS among women treated with enzyme-inducing AEDs, such as carbamazepine, has also been demonstrated in an independent investigation by Hamed et al. 8 This is in contradistinction to the notable relationship that has been demonstrated between the enzyme-inhibiting AED, vaproate. 5 A potential role for the epileptic substrate has been suggested by the finding that among women with unilateral epileptic foci, PCOS is associated with left temporal and right nontemporolimbic foci whereas HA has been found to be more common with right TLE 25, 26 and by the finding that untreated women with primary generalized epilepsy have higher pulse frequency gonadotropin releasing hormone secretion than normal controls. 27 Increased pulse frequency or amplitude of gonadotropin releasing hormone secretion by the hypothalamus results in preferential LH versus FSH secretion by the pituitary, 28, 29 which would promote the development of PCOS.
Pathophysiology of reproductive endocrine disorders in women with epilepsy
The brain controls reproductive function primarily through hypothalamic regulation of pituitary secretion. 29 Regions of the hypothalamus that are involved in the regulation, production, and secretion of gonadotropin-releasing hormone (GnRH) receive extensive direct connections from the cerebral hemispheres, especially from temporolimbic structures that are commonly involved in epilepsy, and most notably from the amygdale.
1,2 Significant relationships have been uncovered through which epilepsy may influence the function of this complex neuroendocrine system.
Animal experimental studies have shown that the amygdala can be parceled into cytoarchitectonically distinct functional divisions that exert opposing modulatory influences on pituitary hormone secretion 30, 31 reproductive function 30, 31 and the resting membrane potentials of individual ventromedial hypothalamic neurons. 32 Following amygdaloid seizures, fos, a protein marker for neuronal activation, is increased in the sexually dimorphic regions of the hypothalamus that are involved in reproductive endocrine secretion and reproductive function, i.e. the medial preoptic, ventromedial, and ventral premammillary nuclei, but much less so in other hypothalamic nuclei. 33 Seizures also decrease GnRH fiber staining in the ventromedial hypothalamus. 34, 35 Both of these responses to unilaterally provoked amygdaloid seizures occur in a laterally asymmetric fashion with significantly and substantially greater involvement ipsilaterally than contralaterally to the seizure focus. 33, 35 Preferential ipsilateral involvement is potentially important because there are lateralized biochemical and physiologic differences between the left and right sides of the limbic system and also of the hypothalamus. Specifically, anovulatory cycles are more common with right than with left unilateral amygdalectomies. 36 GnRH content in the ventromedial hypothalamus of the female rat has been reported to be 50-100% greater in the right ventromedial hypothalamus than in the left ventromedial hypothalamus. 37, 38 The left and right vagus nerves exert different modulatory influences on ovarian structure and function. 37, 38 The experimental findings in the female rat are consistent with the notion that disruption of the normal temporolimbic modulation of hypothalamopituitary function may interfere with ovarian hormonal secretion and promote the development of reproductive endocrine disorders. 39 The findings suggest, moreover, that the reproductive neuroendocrine system, like many other brain systems, shows a lateralized asymmetry that might, by virtue of ipsilaterally predominating effects, contribute to the development of distinct reproductive endocrine disorders in association with unilateral left and right sided epileptic foci. 40 There are also important clinical findings which indicate that reproductive endocrine function differs between women with epilepsy and normal controls and that the laterality and focality of epilepsy may be important determinants of reproductive endocrine function. 7 Unilateral temporolimbic discharges are associated with laterally differing, consistent, predictable, stochastic directional changes in hormonal secretion at all levels of the reproductive neuroendocrine axis, i.e. hypothalamus, pituitary and ovary (Fig. 1) . 7 These directional changes are consistent with the finding that different reproductive disorders may develop in relation to leftand right-sided temporolimbic epilepsy. Specifically, LTLE is associated with significantly higher pulse frequencies of GnRH secretion. 7 Higher GnRH pulse frequency, in turn, is associated with higher LH/FSH ratios and higher serum testosterone levels. This combination of neuroendocrine changes characterizes PCOS and is consistent with the previously suggested association between left unilateral temporolimbic epilepsy (TLE) and PCOS. Ten percent to 20% of women with TLE have been found to have PCOS, in comparison with about 5-6% in the general population. 20 Right unilateral TLE is associated with lower GnRH pulse frequency which is associated with decreased LH and estradiol levels. 2, 7 These features are characteristic of HA. 2, 7, 18, 25, 26 Some hormonal changes can show close temporal relationship to the occurrence of interictal epileptiform Figure 1 Reproductive endocrine function in women with epilepsy and controls. Reproductive endocrine data in medicated and unmedicated women with left and right TLE. Hypothalamic parameters: LHPF was significantly more variable among women with TLE than among controls (6.0 AE 0.7 vs. 5.8 AE 1.7; p < .01). Women with LTLE had higher LHPF than women with RTLE (6.5 AE 1.5 vs. 4.9 AE 1.7; p < .01), regardless of medication use (untreated: 7.2 AE 1.6 vs. 4.0 AE 0.8; p < .01). LHPA was significantly higher among untreated women with TLE than among treated women (3.0 AE 1.4 vs. 2.3 AE 0.7; p = .05) and controls (2.1 AE 0.6; p < .05) without any significant laterality effect. PRLPF showed no significant findings in relation to epilepsy, epilepsy laterality or medication use. PRLPA was significantly more variable among women with TLE than among controls (4.6 AE 6.1 vs. 3.0 AE 1.5; p < .001). Variability was significantly greater among women with RTLE than among women with LTLE (6.7 AE 8.6 vs. 3.0 AE 1.8; p < .001). PRLPA values were significantly greater for treated women with RTLE (8.1 AE 9.6) than for untreated women with RTLE (2.4 AE 0.7; p < .05), as well as women with LTLE (treated: 2.9 AE 1.7; p < .05; untreated: 3.5 AE 2.3; p < .10) and controls (3.0 AE 1.5; p < .05). LH/FSH was significantly greater for women with LTLE than for women with RTLE (1.1 p AE 0.5 vs. 0.65 AE 0.35; p < .01), regardless of medication use (untreated: 1.4 AE 0.6 vs. 0.58 AE 0.10; p < .01). Pituitary parameters: LH was more variable among women with TLE than among controls (4.9 AE 2.5 vs. 4.7 AE 1.5; p = .05). The mean value was higher among untreated women with LTLE (7.1 AE 3.7) than among treated women with LTLE (5.0 AE 1.9; p < .10) and controls (4.7 AE 1.5; p < .10), and more than two-fold greater than the mean value for untreated women with RTLE (3.1 AE 0.9; p = NS). FSH was more variable among women with TLE than among controls (5.9 AE 2.0 vs. 5.2 AE 0.9; p = .01). FSH was significantly higher for women with RTLE (6.7 AE 2.0) than women with LTLE (5.3 AE 1.8; p < .05). This lateralized difference among women with TLE was statistically significant only among treated women (7.1 AE 2.0 vs. 5.4 AE 2.0; p < .05). PRL did not show any significant finding in relation to epilepsy, epilepsy laterality or medication use. Peripheral gland parameters: Testosterone levels were significantly greater for LTLE than RTLE (35 AE 16 vs. 22 AE 9; p < .01) as they were for controls (32 AE 11 vs. 22 AE 9; p < .01). There was no significant finding in relation to medication use. Estradiol levels were significantly greater among controls than women with epilepsy (35 AE 6 vs. 22 AE 8; p < .001) regardless of medication use (untreated: 25 AE 7; p < .01; treated: 21 AE 7; p < .01). E2 levels were significantly greater for LTLE than RTLE (25 AE 7 vs. 18 AE 6; p < .01) and each was significantly less than controls (35 AE 6; p < .01). Lower E2 values with medication use were attributable to the use of enzyme-inducing drugs (E2 for barbiturate, carbamazepine, phenytoin users vs. controls = 14.5 AE 4.5 vs. 35.4 AE 6.2; p < .001) as opposed to non enzyme-inducing drugs (E2 for gabapentin, lamotrigine, valproate users vs. controls = 28.3 AE 9.4 vs. 35.4 AE 6.2; p = N.S.). Untreated women with TLE had substantially lower E2 levels (24.9 AE 7.6) than controls (35. Interictal paroxysmal EEG discharges and closely related reproductive endocrine changes in gonadotropin and prolactin secretion in women with left and right sided unilateral temporolimbic epilepsy. Left temporal discharges were often accompanied by abnormal suppression (>104.3 min without a pules peak) of LH pulsatility and subsequent abnormal >27% elevation in mean baseline LH levels. Right temporal discharges were often followed by abnormally high prolactin pulse peak values and continuation of LH pulsatility. discharges and these vary in relation to the laterality of the discharges (Fig. 2) . 7 Specifically, the occurrence of abnormal prolactin pulse amplitudes predominantly after right temporolimbic discharges, and the suppression of LH pulsatility with subsequent elevation of LH baseline values after left temporolimbic discharges, raise the possibility that paroxysmal interictal discharges may acutely disrupt normal hypothalamopituitary endocrine function. Menstrual disorders have been found to be significantly more common among women with interictal discharges as well with associated abnormal neuroendocrine regulation. 7 AEDs have substantial and differential effects on reproductive hormone levels. 7 There are notable differences between enzyme-inducing and noninducing drugs with the former being associated with lower serum levels of some ovarian and adrenal steroids: estradiol, testosterone and dehydroepiandrosterone sulfate. 7 There is also considerable evidence to suggest that menstrual disorders, anovulatory cycles, polycystic ovaries and PCOS are more common among women who take valproate and, particularly so, when started early during the reproductive years. 15, 41 These findings implicate valproate in the pathophysiology of PCOS.
An alternative and possibly unifying consideration is that PCOS may develop as an interactional effect between AED use and epilepsy. 20, 42 Specifically, there is the possibility that epilepsy may promote PCOS development and that enzyme-inducing AEDs treat not only the epilepsy but also the PCOS by enzyme induction that increases the synthesis of sex hormone binding globulin and the metabolism of testosterone resulting in lower levels of bioavailable testosterone. 20, 42 In contrast, enzymeinhibiting drugs, most notably valproate, may retard the aromatization of testosterone to estrogen and potentiate the development of epilepsy-related hyperandrogenism and hence PCOS. 20, 42 Antiseizure medications other than valproate, therefore, may treat hyperandrogenism and thus PCOS, whereas valproate therapy may not. This mechanism, thereby, could contribute to a higher occurrence of PCOS in valproate-treated women with epilepsy. If this were an extant mechanism, then valproate would not be the primary cause of PCOS, yet its selection as treatment may be an important factor.
Reproductive dysfunction in men with epilepsy
Diminished libido or potency occurs in approximately 20% of men with epilepsy as determined by standardized questionnaire survey. 4, 43 Older studies, using mostly structured or unstructured interviews, found higher frequencies ranging from 38 to 71%. 3, 6, [43] [44] [45] [46] [47] [48] [49] Abnormal semen analysis, including decreased sperm count, abnormal morphology or impaired motility, have been reported in upwards of 90% of men with epilepsy. 41, 44, 46 Men with idiopathic epilepsy are only 36% as likely as male unaffected siblings to ever father a pregnancy. 16 This reduction is associated with localization-related epilepsy, onset of seizures before 20 years of age, and absence of a family history of epilepsy. 16 The effect is mitigated by reduced marital rates. Among married men with epilepsy, reproductive disadvantage was confined to those with onset before 10 years of age. 16 Reproductive endocrine dysfunction in men with epilepsy Hypogonadism refers to diminished gonadal function as determined by low serum testosterone level and/or decreased or abnormal sperm production. 6 It can manifest as diminished sexual interest, potency, fertility, energy, mood, competitive drive, bone and muscle mass, and secondary sexual characteristics. Physical signs include a loss of male escutcheon, gynecomastia and testicular atrophy. The clinical impression of hypogonadism can be verified by laboratory testing. It may be hypogonadotropic, hypergonadotropic or associated with functional hyperprolactinemia. 3 Testosterone exists in three major forms: (1) tightly bound to sex hormone binding globulin (SHBG, 45-50%), (2) loosely bound to albumin (50-55%), and (3) unbound (1-2%). 6 The albumin-bound and free portions are available to tissues and, therefore, constitute the clinically important bioavailable portion. Measures of bioavailable testosterone (BAT) suggest that hypogonadism may occur in one-third of men with temporolimbic epilepsy 4, 43 BATshows a substantially earlier and greater age-related decline in men with epilepsy than in controls. 4, 43 In a sample of men with localization-related epilepsy, we found that BAT fell below normal control levels in 11% of men between 20 and 30 years, 27% between 30 and 40 years and 89% between 40 and 50 years of age. 43 Several 4, [46] [47] [48] [49] but not all, 50 investigations have found significant relationships between reduced serum BAT measures and sexual dysfunction. Men with epilepsy may show evidence of sexual dysfunction in the setting of lownormal BAT levels at which men in the general population may not show clinical manifestations. 3, 4, 6, 43 This may constitute an argument against the importance of the BAT level. Alternatively, higher BAT levels may be required for normal sexual function in the setting of the altered brain substrate of temporolimbic epilepsy.
Pathophysiology of reproductive endocrine disorders in men with epilepsy
The etiology of hypogonadism as well as reproductive and sexual dysfunction in men with epilepsy has been attributed to a number of possible causes. These include: (1) psychosocial stress; (2) AEDs; and (3) epilepsy itself. 6 Psychosocial stress associated with epilepsy may play an important role in hypogonadism. [51] [52] [53] [54] [55] [56] From a neuroendocrine perspective, stress response involves the activation of the hypothalamo-pituitary-adrenal (HPA) axis. 6, [52] [53] [54] [55] [56] Cortisol levels are higher in individuals with epilepsy than in controls, not unlike individuals with depression. 53 Unlike depression, however, diurnal variation is often lost in epilepsy. 53 Factors that increase the activity of the HPA axis interfere with reproductive endocrine secretion as well as reproductive function 6, [52] [53] [54] [55] [56] and may contribute to seizure exacerbation. 6 Stress increases the release of proopiomelanocortin (POMC) the precursor protein that is cleaved to form ACTH and endorphin, 54, 56 both of which inhibit gonadotropin secretion and reproductive function. 52, 56 ACTH increases cortisol secretion; endorphins increase dehydroepiandrosterone production. Both of these steroids have GABA-negative allostearic modulatory properties that can lower seizure thresholds and increase anxiety. 6, 57 Enzyme-inducing AEDs can directly suppress gonadal testosterone synthesis, increase testosterone binding by the induction of sex hormone binding globulin (SHBG) synthesis, and increase serum estradiol levels in absolute or relative terms. 4, 43, 58 Although constituting only 1% of the total reproductive steroid, estradiol exerts one-half of the negative feedback on the hypothalamopituitary axis. 6 Therefore, a small increase in estradiol level, presumably as a result of AED induced increase in aromatase activity, could have a disproportionately large negative feedback effect on gonadotropin production, thereby contributing to hypogonadism. In a comparison of sexual/reproductive function and reproductive hormone levels among 85 men with epilepsy who took various AEDs [25 on carbamazepine (CBZ), 25 on phenytoin (PHT), 25 on lamotrigine (LTG) and 10 untreated for at least 6 months (No AED)] and 25 controls, Herzog et al. 4, 43 found that sexual function scores (S-scores), hormone levels (bioactive testosterone, estradiol), hormone ratios (bioactive testosterone/bioactive estradiol) and gonadal efficiency (bioactive testosterone/ luteinizing hormone) were significantly greater in the control and LTG treated groups than in the CBZ and PHT treated groups. Sex hormone binding globulin was significantly higher in the CBZ and PHT groups than in all other groups. Among the significant findings were the following. S-scores were below the control range in 20% of the men with epilepsy, including 32% on CBZ, 24% on PHT, 20% on no AEDs and 4% on LTG. Bioactive testosterone was below the control range in 28.2%, including 48% on CBZ, 28% on PHT, 20% on no AEDs and 12% on LTG. Among men with epilepsy who had low S-scores, 70.6% had bioactive testosterone levels below the control range as compared to 17.6% among men with normal S-scores. Among men with epilepsy who had abnormally low bioactive testosterone, 50.0% had low S-scores; among men with normal bioactive testosterone, 8.2% had low S-scores. Bioactive testosterone decline with age was greater among men with epilepsy than among controls and notably greater in the CBZ and PHT groups than in the LTG and untreated groups. Overall, sexual function, bioavailable testosterone levels and gonadal efficiency in men with epilepsy who took lamotrigine were comparable to control and untreated values and significantly greater than with carbamazepine or phenytoin treatment.
The temporolimbic system is one of the most common sites of origin or involvement in adult epilepsy. It also has integral roles in reproductive endocrine regulation and feedback as well as in sexual and reproductive function. 1, 3, 6 Consequently, the development of epileptiform discharges in medial temporal lobe structures may disrupt hypothalamic regulation of pituitary secretion and hence alter gonadal function and reproductive function (Fig. 3) . 1, 3, 6 Experimental animal investigations have shown that focal limbic seizures, as well as generalized seizures, disrupt normal gonadal structure, physiology and serum androgen levels in the male rat, 59 and that the induction of seizures in the amygdala, but not in the motor cortex, produces hyposexuality in the male cat. 60 Clinical studies suggest that temporolimbic epilepsy may be associated with altered gonadotropin response to GnRH infusion regardless of AED use. 61 Mean baseline LH and LH pulse frequency are significantly more variable among men with epilepsy than among controls and may show bidirectional changes that relate to EEG laterality. 62 Epileptiform discharges in men are accompanied by acute elevations in prolactin levels 63 and may also be accompanied by acute changes in patterns of LH secretion. 6 Quigg et al. 64 have found that interictally, LH pulse frequency and mean concentration are lower and pulse amplitudes are higher than in controls. Postictally, they found no change in mean pulse frequency but did detect a significant change in the regularity of pulse occurrence. Clinically, there may be a greater occurrence of sexual dysfunction in men with right, rather than left, lateralized temporolimbic epilepsy. 3, 65, 66 There is also animal experimental evidence to suggest that the left and right sides of the hypothalamus may exert different effects on sexual function. 67 Testosterone levels may be lower in men with temporal foci as compared to extratemporal foci. 68 Successful temporal lobectomy in hypogonadal men with intractable seizures has been associated with normalization of testosterone levels 69 and improvement in sexual interest and function. 70 A remarkably high frequency of abnormal findings in semen analysis has been reported to occur among untreated as well as treated men with epilepsy. 44, 71 Changes in reproductive steroid concentrations may impact seizure tendencies as well as reproductive function. While estrogen is proconvulsant and progesterone is anticonvulsant in most adult animal models of LRE, the effect of testosterone on experimental seizures appears to be mixed. This may be related to its ready metabolism by aromatase to estradiol which has neuroexcitatory effects, 72 while it can also be metabolized by reductase to dihydrotestosterone and further to androstanediol, a potent GABAergic steroid with antiseizure properties. 6, 73 While testosterone replacement has proven only moderately effective in restoring sexual function, possibly because of its ready metabolism to estrogen, especially in the setting of AEDs, one pilot study has reported superior results using combined treatment with testosterone and an aromatase inhibitor that blocked the transformation of testosterone to estradiol. 74 Combined therapy was associated with seizure reduction as well. 74 The neuromodulatory role of reproductive steroids suggests that a greater understanding of neuroendocrine regulation in men with epilepsy may be important not only for reproductive function but also for optimal management of seizure disorders. Figure 3 Gonadal steroid secretion is regulated by pituitary gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), that are, in turn, regulated by the pulsatile secretion of gonadotropin releasing hormone (GnRH) by sexually dimorphic reproductive endocrine nuclei in the hypothalamus. The amygdala can be parceled into two cytoarchitectonically distinct functional divisions, corticomedial and basolateral, that exert opposing modulatory influences on the hypothalamic regulation of pituitary secretion. The amygdala also regulates the autonomic (sympathetic -Symp N.S. and parasympathetic -Vagus) innervation of the testes, that likely play a trophic as well as endocrine regulatory function, and receives vagal afferents (dotted line)that impact amygdaloid excitability. Antiepileptic drugs differentially affect gonadal testosterone biosynthesis, hepatic sex hormone binding globulin (SHBG) production, and aromatization and reduction of testosterone to potent glutamatergic neuroexcitatory (estradiol -E2) and GABAergic neuroinhibitory (androstanediol -ADiol) metabolites that may feed back (dashed line) to modulate temporolimbic neuroexcitability and seizures.
